Asim Kichloo

Asim Kichloo is a Senior Professor and Chair of Internal Medicine and Geriatrics at the University of North Texas Health Science Center. His research focuses on outcomes research in critical care, cardiology, and epidemiology, with specific interests in acute kidney injury in intensive care, atrial fibrillation management in obesity, and cardiovascular disease. His recent publications include studies on chronic kidney disease’s impact on acute respiratory distress syndrome outcomes (Canadian Respiratory Journal, 2026) and comparative efficacy of venetoclax-based regimens in chronic lymphocytic leukemia (Annals of Hematology, 2025). He also investigates hematologic malignancies, including minimal residual disease in acute lymphoblastic leukemia, and leads systematic reviews on targeted therapies like zanubrutinib. His work integrates public health perspectives with clinical medicine, advancing evidence-based care across multiple specialties.